Rhumbline Advisers Astellas Pharma Inc Unsponsore Transaction History

Rhumbline Advisers

$104 Billion
Q1 2025

A detailed history of Rhumbline Advisers transactions in Astellas Pharma Inc Unsponsore stock. As of the latest transaction made, Rhumbline Advisers holds 33,873 shares of ALPMY stock, worth $336,358. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,873

Previous 35,945 5.76%

Holding current value

$336,358

Previous $347,000 3.17%

% of portfolio

0.0%

Previous 0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 08, 2025	SELL	$9.15 - $10.01 $18,958 - $20,740	-2,072 Reduced 5.76%	33,873 $336,000
Q4 2024 Jan 30, 2025	SELL	$9.64 - $12.3 $8,512 - $10,860	-883 Reduced 2.4%	35,945 $347,000
Q3 2024 Nov 12, 2024	BUY	$9.81 - $12.64 $31,784 - $40,953	3,240 Added 9.65%	36,828 $422,000
Q2 2024 Aug 01, 2024	SELL	$9.27 - $10.79 $40,194 - $46,785	-4,336 Reduced 11.43%	33,588 $331,000
Q1 2024 May 09, 2024	BUY	$10.62 - $12.28 $37,010 - $42,795	3,485 Added 10.12%	37,924 $407,000
Q4 2023 Feb 08, 2024	SELL	$11.36 - $13.81 $3,635 - $4,419	-320 Reduced 0.92%	34,439 $409,000
Q3 2023 Nov 09, 2023	BUY	$13.85 - $15.55 $207 - $233	15 Added 0.04%	34,759 $481,000
Q2 2023 Aug 08, 2023	BUY	$14.05 - $16.79 $488,153 - $583,351	34,744 New	34,744 $516,000

Others Institutions Holding ALPMY

# of Institutions

Shares Held

239K

Call Options Held

Put Options Held

View Full List

About Astellas Pharma Inc Unsponsore

Ticker ALPMY
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,827,069,952
Market Cap $18.1B

More about ALPMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Astellas Pharma Inc Unsponsore Transaction History